$8.37
-0.34-3.9%
가까이에: Nov 20, 4:00 PM EST
$8.37
N/A
시간외: Nov 20, 4:00 PM EST

The average analyst price target for Telix Pharmaceuticals is $21.20, 153.3% above the current price. Of 5 analysts, 4 rate it Buy and 1 Hold. Targets range from $20 to $22. The latest change came on Jul 7, 2026, when Citigroup lowered its price target on Telix Pharmaceuticals from $22.50 to $22 and kept a Buy rating.
Price Target Range — 9 Quarters
Analyst Consensus — 5 Analysts
Rating Trend — Last 9 Months